Drug Interaction Analysis
6 weeks · 0 milestones
Analyse a real polypharmacy case for clinically significant drug interactions. Proof requires: (a) a documented case (real or realistic) with the patient's medication list (minimum 5 concurrent medications); (b) identification of all clinically significant interactions using a recognised interaction checker (Stockley's, BNF, Drugs.com interaction checker) with the mechanism of each interaction documented; and (c) a recommended management plan for each interaction identified. Reviewed by a registered pharmacist. The proof is the analysis and reasoning — not AI-generated output submitted as evidence. The pharmacist confirms the interaction assessment is accurate before the proof is considered complete.
Milestone map
Milestone map
3 milestones
Build a reference document classifying at least 30 clinically significant drug-drug interactions across four categories: pharmacokinetic (CYP enzyme interactions, protein binding, renal/hepatic clearance changes), pharmacodynamic (additive, synergistic, antagonistic), high-risk interactions (narrow therapeutic index drugs: warfarin, lithium, digoxin, phenytoin), and common in practice (e.g. antibiotics + OCP, ACE inhibitors + potassium-sparing diuretics, NSAIDs + anticoagulants). For each interaction, document: mechanism type, clinical consequence, severity, and monitoring approach.
Proof required
Submit your interaction reference document (minimum 30 interactions across all four categories). Include your primary reference source (BNF, Stockley's, or equivalent).
What gets checked
- All four interaction categories are populated — not weighted entirely toward the common-in-practice category.
- Each entry includes mechanism type, clinical consequence, severity, and monitoring approach — partial entries don't count.
- High-risk category includes at least 6 interactions involving narrow therapeutic index drugs.